Children with isolated hypospadias have different hormonal profile compared to those with associated anomalies

Simmi K Ratan1, Satish Aggarwal, Tarun Kumar Mishra

  • 1Department of Pediatric Surgery, Maulana Azad Medical College, New Delhi, India. drjohnsimmi@yahoo.com

Insights

Children with hypospadias and associated anomalies show lower androgen levels, potentially explaining other developmental issues. Isolated hypospadias cases exhibit hormonal differences, including higher FSH, suggesting potential long-term reproductive concerns.

Area of Science:

  • Pediatric Endocrinology
  • Urology
  • Reproductive Medicine

Background:

  • Hypospadias is a common congenital condition affecting the urethra.
  • Hormonal imbalances may play a role in the development of hypospadias and associated anomalies.

Purpose of the Study:

  • To compare the hormonal profiles of children with isolated hypospadias (H) versus those with hypospadias and associated anomalies (HO) and healthy controls (C).

Main Methods:

  • Prospective study involving 100 children with isolated hypospadias, 23 with hypospadias and anomalies, and 100 controls (0-12 years).
  • Serum hormone levels (gonadotropins, DHEA-S, estrogen, progesterone, testosterone, DHT) were measured pre- and post-hCG stimulation.
  • Statistical analysis compared hormonal differences between groups (p < 0.05 significant).

Main Results:

  • Isolated hypospadias (H) group showed higher FSH, lower estrogen, and lower DHEA-S compared to controls.
  • Hypospadias with anomalies (HO) group exhibited higher FSH, lower basal and peak testosterone, and lower androgens compared to H.
  • HO group also had higher estrogen and progesterone levels than the H group.

Conclusions:

  • Lower androgen output in HO may link to associated anomalies like undescended testes.
  • Elevated FSH in hypospadiacs suggests potential Sertoli cell dysfunction and future reproductive issues.
  • Leydig cell function appears more compromised in children with hypospadias and associated anomalies.
Abstract

Related Concept Videos

Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...